Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-1780 in Primary Aldosteronism
NCT07470983Phase 2Active, not recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-1780 in primary aldosteronism (PA), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Apr 2026; status: active, not recruiting.
02
Drugs
HRS-1780
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT07470983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07470983.